Evo Fund has disclosed a 5.05% stake in SANKO Marketing Foods, saying it holds 2,007,700 shares out of 39,762,949 outstanding. The filing also says the fund plans to buy, on June 1, a third-party allotted convertible bond with warrants for ¥300 million and another 100,000 warrants for ¥600,000. The convertible’s initial exercise price is ¥90.9 per share, while each warrant covers 100 common shares.
That matters because this is not just a plain equity position, it is a setup with built-in optionality. If the instruments are taken up and later exercised, the cap table gets more crowded, and quickly. The filing says the holding is for pure investment, though it also leaves the door open for management advice depending on conditions, which is a polite way of saying the relationship may not stay purely passive forever.
There is also a funding wrinkle worth noting: the report lists zero own funds, zero other sources and zero acquisition funding in the summary fields, while the detailed sections show the current position is supported by borrowed shares totaling 2,007,700. In other words, this is a filing about exposure and optionality, not a neat little cash-purchase story.
For business readers, the near-term watchpoint is simple, June 1 is the disclosed timing for the next step. The less simple part is what those securities mean later, once warrants start behaving like actual shares instead of decorative paperwork.